Indian study finds 1st evidence on how nanoplastics from single-use PET bottles harm body

PIB Photo

New Delhi, (IANS): Nanoplastics derived from single-use PET bottles can directly disrupt key biological systems that are vital for human health, according to a study led by the Institute of Nano Science and Technology, Mohali (INST), an autonomous institute of the Department of Science and Technology (DST), on Thursday.

Nanoplastics, found in food and water, are a global concern and are increasingly being detected inside the human body. But their exact effects remain poorly understood.

While many studies had focused on how plastics pollute the environment or damage host tissues, almost nothing was known about their direct impact on beneficial gut microbes that are central to human health.

The team led by Prashant Sharma and Sakshi Dagariya from the Chemical Biology Unit at INST found the first clear evidence of profound consequences to human health.

The researchers found that long-term exposure reduced bacterial growth, colonisation, and protective functions, while increasing stress responses and sensitivity to antibiotics.

"Together, the findings explain that nano-plastics from everyday plastics are biologically active particles that can interfere with gut health, blood stability, and cellular function," said the researchers in the paper published in the journal Nanoscale Advances.

The team recreated Nano-plastics from PET bottles in the laboratory and tested them across three key biological models.

A beneficial gut bacterium, Lactobacillus rhamnosus, was used to see how nanoplastics affect the microbiome.

At higher concentrations, nanoplastics were found to disrupt red blood cell membranes and cause premature destruction of the cells.

Further, the team also found that prolonged exposure led to DNA damage, oxidative stress, apoptosis, and inflammatory signalling, alongside shifts in energy and nutrient metabolism.

"The nanoparticles induce DNA damage, oxidative stress, and inflammatory responses in human epithelial cells during prolonged exposure, posing risks to human health that were previously unrecognised," the researchers said.Beyond human health, the insights can extend to agriculture, nutrition, and ecosystem studies, where microbial balance and plastic pollution intersect, they noted. Indian study finds 1st evidence on how nanoplastics from single-use PET bottles harm body | MorungExpress | morungexpress.com
Read More........

Scorpion Venom May Provide the Next Breast Cancer Breakthrough

– credit Marino Linic

Scientists in Brazil are currently testing to see if the venom of an Amazonian scorpion could be used to poison breast cancer tumors.

Researchers at the University of São Paulo’s Preto School of Pharmaceutical Sciences (FCFRP-USP) have long worked to clone and express proteins from rattlesnake and scorpion venom with hopes of transforming these powerful compounds into medicines.

Recently, their work identified that venom of the scorpion Brotheas amazonicus appears to attack breast cancer cells in a way similar to a widely used chemotherapy medication.

These early findings were generated through a collaboration with scientists from the National Institute for Amazonian Research (INPA) and the Amazonas State University (UEA).

“Through bioprospecting, we were able to identify a molecule in the species of this Amazonian scorpion that is similar to that found in the venoms of other scorpions and that acts against breast cancer cells,” said Eliane Candiani Arantes, a professor at FCFRP-USP and the coordinator of the project.

Arantes and her team identified two neurotoxins in scorpion venom with immunosuppressive effects. Working with collaborators at INPA and UEA, they found a peptide named BamazScplp1 in the venom of Brotheas amazonicus that appears to have anti-tumor potential.

Laboratory tests showed that the peptide’s impact on breast cancer cells was comparable to paclitaxel, a commonly prescribed chemotherapy treatment. It primarily triggers necrosis, a form of cell death previously associated with molecules from other scorpion species.

Arantes and her team have isolated other components of venoms from scorpions and from snakes that have been used to help develop other clinical applications, including an internal wound sealant that mimics the body’s natural clotting and scaffolding processes. It’s undergoing trials for use in nerve repair, bone healing, and restoring movement following spinal cord injury.Next time you see a scorpion, and think it a nasty creepy crawly that will send you to the hospital, show a bit of grace; they might help save a woman’s life some day. Scorpion Venom May Provide the Next Breast Cancer Breakthrough
Read More........

Indian scientists find genetic clues to tackle oral cancer among women

Photo: https://www.nibmg.ac.in)

New Delhi, (IANS) A team of Indian scientists has discovered oral cancer-causing driver gene mutations in women patients in southern parts of the country.

The team from the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Bengaluru and the BRIC-National Institute of Biomedical Genomics (NIBMG), Kalyani, in collaboration with clinicians from Sri Devraj Urs Academy of Higher Education and Research (SDUAHER), Kolar, conducted a female-centric study on oral cancer in India with a unique tobacco chewing habit.

This study led by Professor Tapas K Kundu, JNCASR, Bengaluru aimed to understand what makes cancers in women unique, how the disease manifests and progresses in female patients and how we can treat them better.

The team also used artificial intelligence (deep learning) to digitally analyse tumour tissues. This revealed two distinct groups of female patients, each with a different immune response in their tumours.

India carries one of the world’s heaviest burdens of oral cancer with alarmingly high rates witnessed among women in certain regions, especially in southern and northeast India, due to the widespread habit of chewing tobacco-infused betel quid, gutka, and related products.

While the disease is widely studied in men, oral cancer in women has often remained under the radar.

The study was performed on paired tumour and blood samples from female OSCC-GB patients with a unique regional tobacco-chewing habit (Kaddipudi), commonly observed among women in the Kolar district of Karnataka.

Analysis of this women-centric cohort has revealed a unique driver mutation implicated in oral tumorigenesis.

This investigation, published in the Clinical and Translational Medicine Journal, was specifically designed to uncover the biological underpinnings of the disproportionately aggressive, highly recurrent, and life-threatening forms of oral cancer that affect Indian women.

Using cutting-edge whole-exome sequencing, the researchers identified ten key genes with significant mutations in the female oral cancer cohort from Kolar, Karnataka.

Although two of the major genes, CASP8 and TP53, were found to be highly mutated in these patients, uniquely, CASP8 seems to be the driver mutation (cancer-causing), which is quite different compared to previously studied mutations in oral cancer patients (largely men).

The findings suggest that co-occurring TP53 and CASP8 mutations confer a markedly aggressive and lethal phenotype in oral cancer.The team is now focused on delineating the molecular mechanisms of oncogenesis driven by this novel driver mutation within the background of TP53 alterations for the next phase of the research. Indian scientists find genetic clues to tackle oral cancer among women | MorungExpress | morungexpress.com
Read More........

Australia leads first human trial of one-time gene editing therapy to halve bad cholesterol


IANS Photo

Melbourne, November 10 (IANS): Researchers in Australia have led a first-in-human trial for a breakthrough gene-editing therapy that halves bad cholesterol and triglycerides in people with difficult-to-treat lipid disorders.

The trial tested CTX310, a one-time CRISPR-Cas9 gene-editing therapy that uses fat-based particles to carry CRISPR editing tools into the liver, switching off the ANGPTL3 gene. Turning off this gene lowers LDL (bad) cholesterol and triglycerides, two blood fats linked to heart disease, according to a statement released Monday by Australia's Monash University.

The Victorian Heart Hospital, operated by Monash Health in partnership with Monash University, treated three of 15 patients aged 18-75 years with difficult-to-treat lipid disorders in phase 1 of the global trial conducted across Australia, New Zealand, and Britain, the statement said, Xinhua news agency reported.

At the highest dose, a single-course treatment with CTX310 resulted in a mean reduction of LDL cholesterol by 50 per cent and triglycerides by 55 per cent, remaining low for at least 60 days after two weeks of treatment, it said, adding LDL cholesterol and triglycerides were reduced by nearly 60 per cent among all participants with various doses, with only mild, short-term side effects reported.

Importantly, CTX310 is the first therapy to achieve large reductions in both LDL cholesterol and triglycerides at the same time, marking a potential breakthrough for people with mixed lipid disorders who have elevations in both, according to the trial published in the New England Journal of Medicine.

"The possibility of a single-course treatment with lasting effects could be a major step in how we prevent heart disease," said Stephen Nicholls, Director of the Victorian Heart Hospital, and study lead investigator."It makes treatment easier, reduces ongoing costs, relieves pressure on the health system, all while improving a person's quality of life," Nicholls said, emphasising plans to focus on larger and more diverse patient populations in future trials of CTX310. Australia leads first human trial of one-time gene editing therapy to halve bad cholesterol | MorungExpress | morungexpress.com
Read More........

ICRISAT develops portable technology for testing crops' nutrition level



The International Crops Research Institute for the Semi-Arid Tropics (ICRISAT) on Thursday announced that its researchers are leading a transformation in crop testing, combining AI-driven models and pocket-size near-infrared spectroscopy (NIRS) devices.

These portable sensors allow for quick evaluation of nutrition levels in indigenous food grains right at the farmer's gate or in research fields.

ICRISAT Director General, Dr Jacqueline d'Arros Hughes, championed the integration of this disruptive technology into breeding pipelines and key points of relevant value chains.

Aligned with the UN Food and Agriculture Organisation (FAO) strategy, she foresees the tool as a catalyst for the production of nutrient-dense crops, both in breeding programmes and in farmers' fields, a crucial element in the global fight against malnutrition.

"This technology is poised to expedite the breeding of nutrient-dense crops while facilitating their integration into the value chain. Our goal with this intervention is to provide quality assurance for the distribution of nutritionally fortified crops, so that they reach those who need them most," she added.

Traditionally, assessing the nutritional quality of grains and feedstock could take a number of weeks, involving manual or partially automated processes and laboratory instruments.

In contrast, mobile NIRS devices are more cost-effective and can assess over 150 samples per day per person, ICRISAT said.

These non-destructive and robust grain quality measuring devices provide timely information on grain composition and can be used to promote quality-based payments in the market—benefiting food producers, grain processing industries, and farmers alike.

"We see the adoption of portable technology for assessing grain quality as an important step in decentralising and democratising market systems, essential to promote the consumption of nutri-cereals. This transition can facilitate quality-driven payments for farmers, while providing quality assurance to health-conscious households moving forward," noted Dr Sean Mayes, Global Research Director of the Accelerated Crop Improvement Program at ICRISAT.

In Anantapur in Andhra Pradesh, ICRISAT recommends its Girnar 4 groundnut variety to ensure premium prices for farmers and to differentiate the crop from lower-value varieties. ICRISAT's Girnar 4 and Girnar 5 groundnut varieties boast oleic acid levels of 75-80 per cent, far surpassing that of the standard variety at 40-50 per cent.

Oleic acid is a heart-healthy monounsaturated fatty acid, which holds considerable importance for the groundnut market, as it provides new end-uses for the crop. Growing consumer awareness of its advantages spurred market demand for high oleic acid content in oils and related products.

This pioneering approach, initially applied in peanut breeding, could be replicated across other crops, offering efficient and cost-effective solutions to address poor nutrition.

ICRISAT's Facility for Exploratory Research on Nutrition (FERN laboratory) is expanding its prediction models to encompass various traits and crops beyond groundnuts."We are currently focusing on developing methods to assess oil, oleic acid, linoleic acid, carotenoids, starch, moisture, and phosphorus in various cereals and legumes, such as finger millet, foxtail millet, pearl millet, sorghum, maize, wheat, chickpea, mungbean, common bean, pigeon pea, cowpea, soybean, groundnut, and mustard," said Dr Jana Kholova, Cluster Leader. Crop Physiology and Modelling, ICRISAT. ICRISAT develops portable technology for testing crops' nutrition level | MorungExpress | morungexpress.com
Read More........

Parkinson's disease causes progressive changes in brain's blood vessels: Study

IANS Photo

New Delhi, (IANS): Researchers in Australia have found that Parkinson's disease causes significant and progressive changes in the brain's blood vessels, changing the understanding of the disease.

While Parkinson's disease is characterised by alpha-synuclein protein deposits, the research demonstrated that region-specific changes to blood vessels in the brain underlie disease progression, Xinhua news agency reported.

"Traditionally, Parkinson's researchers have focused on protein accumulation and neuronal loss, but we have shown the impacts on our cerebrovasculature -- the blood vessels in our brain," said Derya Dik, postdoctoral student at Neuroscience Research Australia (NeuRA).

"Our research identified region-specific changes in the brain's blood vessels, including an increased presence of string vessels, which are non-functional remnants of capillaries," Dik added.

NeuRA researchers, in collaboration with the University of New South Wales and the University of Sydney, also observed changes relating to how blood flows in the brain and how the blood-brain barrier operates.

The findings, published in the journal Brain, may also help open up new treatment avenues.

Researchers believe that targeting these progressive, region-specific changes may be able to slow disease progression and improve outcomes for patients suffering from Parkinson's disease.

In addition to exploring what these findings mean for people with Parkinson's disease, the researchers are considering impacts for other neurodegenerative disorders.

"We are now investigating whether similar cerebrovascular changes are present in post-mortem brain tissue from individuals with Alzheimer's disease and dementia with Lewy bodies tissue," Dik said."This study may lead to new treatment options for people with Parkinson's disease, but we also want to better understand the contribution of vascular pathology in these other neurodegenerative disorders and explore whether this can reveal new targets for therapies and treatments for people with those conditions also," the researcher said. Parkinson's disease causes progressive changes in brain's blood vessels: Study | MorungExpress | morungexpress.com
Read More........

Indian researchers develop smart portable device to detect toxic pesticides in water, food

IANS Photo

New Delhi, (IANS): A team of researchers from the Indian Institute of Technology (IIT) Madras and Panjab University has developed a portable, automated optical device capable of detecting extremely low concentrations of pesticide residues in water, food, and the environment that can pose serious risks to human and environmental health.

Conventional laboratory methods for detecting such residues, particularly the commonly used organophosphate Malathion, are expensive, time-consuming, and require skilled personnel.

The new research, supported by the Department of Science and Technology, under its ‘Technology Development and Transfer’ Programme, addressed the challenge by designing a field-deployable, user-friendly device that offers real-time, ultra-sensitive pesticide detection.

The new ‘Smart MDD (Malathion Detection Device)’ is a colourimetric detection system that employs gold nanoparticles (AuNPs) and comes with an aptamer molecule engineered to recognise Malathion specifically.

The interaction causes a visible colour shift -- from red to blue --indicating the presence of the pesticide, a change that the device’s built-in optical system precisely measures. This automated process eliminates manual handling and enables quick, reliable results, said the team. The findings were published in the peer-reviewed journal Review of Scientific Instruments.

“This technology can have a significant real-world impact. It can help farmers, food safety agencies, and environmental regulators rapidly monitor pesticide contamination on-site -- whether in irrigation water, produce, or soil -- thereby ensuring compliance with safety standards and reducing public health risks," Prof. Sujatha Narayanan Unni, Department of Applied Mechanics and Biomedical Engineering, IIT Madras, told IANS.

"It can also aid in tracking pesticide runoff in water bodies, a major environmental concern,” Unni added.

The team demonstrated a detection limit of about 250 picomolar and correlation with lab spectrophotometer results -- metrics that are rarely seen in portable devices.

Currently tested under laboratory conditions, the device will next undergo validation with real-world samples such as fruits, vegetables, and field water sources."We plan to extend the platform to detect a broader range of pesticides, strengthening its role in sustainable agricultural management and environmental monitoring,” Dr. Rohit Kumar Sharma, Department of Chemistry and Centre for Advanced Studies in Chemistry, Panjab University, told IANS. Indian researchers develop smart portable device to detect toxic pesticides in water, food | MorungExpress | morungexpress.com
Read More........

Nanotechnology breakthrough may boost treatment for aggressive breast cancer: Study

IANS Photo

Sydney, (IANS): Researchers in Australia are developing next-generation nanoparticles to supercharge current treatments for triple-negative breast cancer (TNBC) -- one of the most aggressive and deadly forms of the disease.

The researchers are designing innovative iron-based nanoparticles, or "nano-adjuvants," small enough to fit thousands on a single strand of hair, to strengthen the body's immune response against TNBC, according to the University of Queensland's Australian Institute for Bioengineering and Nanotechnology (AIBN) on Monday, Xinhua news agency reported.

Unlike other breast cancers, TNBC lacks the proteins targeted by some of the conventional treatments used against other cancers, making effective therapy a significant challenge, according to Prof. Yu Chengzhong from the AIBN.

"Despite the promise of immunotherapy, its effectiveness against triple-negative breast cancer is extremely limited, which is leaving too many women without options -- and that's what our research is trying to change," Yu said.

The nanoparticles are designed to enhance the activity of T-cells, the white blood cells used by the immune system to fight disease, within the tumour microenvironment, improving the immune system's ability to recognise and attack cancer cells, according to Yu.

Supported by a 3 million Australian dollar ($1.89 million) National Health and Medical Research Council grant, the five-year research project aims to bridge a critical treatment gap, and could pave the way for clinical applications, not only for TNBC but also for other hard-to-treat cancers like ovarian cancer.

With over two decades of experience in nanotechnology and nanomedicine, Yu hopes this breakthrough will transform cancer treatment by making immunotherapy more effective for patients with aggressive solid tumours."This research will push the boundaries of science to find innovative treatments that change the way we fight this cancer, offering hope for women facing devastating outcomes," said AIBN Director Alan Rowan. Nanotechnology breakthrough may boost treatment for aggressive breast cancer: Study | MorungExpress | morungexpress.com
Read More........

Japanese researchers successfully regenerate bone using stem cells


IANS Photo

New Delhi, (IANS): A team of researchers from Japan has successfully treated spinal fractures in animal models using stem cells from fatty tissue.

The team from the Osaka Metropolitan University used stem cells extracted from adipose -- the body’s fatty tissue -- to treat spine fractures in rats similar to those caused by osteoporosis in humans.

These cells offer the advantages of being easy to collect, even from elderly individuals, and causing little stress to the body, suggesting a non-invasive way of treating bone diseases.

Bone regeneration and strength were significantly improved in rats transplanted with the adipose tissue (ADSCs).

The genes involved in bone formation and regeneration were also activated. The study was published in Bone and Joint Research.

“This study has revealed the potential of bone differentiation spheroids using ADSCs for the development of new treatments for spinal fractures,” said Yuta Sawada, a student at the varsity's Graduate School of Medicine.

“Since the cells are obtained from fat, there is little burden on the body, ensuring patient safety. This simple and effective method can treat even difficult fractures and may accelerate healing,” added Dr. Shinji Takahashi.

Osteoporosis is a disease that causes bones to become brittle and prone to fractures. Among osteoporosis-related fractures, compression fractures of the spine -- known as osteoporotic vertebral fractures -- are the most common type of fracture and pose a serious problem, leading to a need for long-term care and a significant decline in quality of life.

The team used stem cells, which are multipotent, meaning that they can be differentiated into many different cell types.

They developed ADSCs into bone-differentiated spheroids -- three-dimensional spherical clusters -- and combined it with beta-tricalcium phosphate, a material widely used for bone reconstruction, to successfully treat rats with spinal fractures.“This technique is expected to become a new treatment that helps extend the healthy life of patients,” Takahashi said. Japanese researchers successfully regenerate bone using stem cells | MorungExpress | morungexpress.com
Read More........

Recyclers Switch from Smelting to Solvents, Recovering Precious Metals from E-waste with Fewer Emissions

credit Unsplash Vlad

A startup in the UK is recovering important manufacturing metals without energy-hungry smelting methods.

Using an intense solvent at room temperature, shredded circuit boards can have plastic retaining components left behind, while metals like gold, cobalt, and copper are selectively dissolved and made available for recovery with simple magnets.

It’s one part recycling research, one part national security, as governments around the world attempt to secure long-term supplies of these metals for tech and defense sectors.

Look across the hard news sections from around the world, from the financial pages to politics, conflict, and international development, and these days you’ll inevitably find two alternating terms that stand out for their relative novelty and repetition: ‘critical’ or ‘rare earth’ minerals.

These terms refer to what many Americans and Brits have taken for granted over the years: copper, lithium, nickel; which have now become key components in geopolitical strategies worldwide.

Yet one of the richest sources of these minerals in the West could be the circuit boards embedded in the millions of broken and discarded devices that pile up higher and higher every year.

“What you see with this pile of electricals is actually central to geopolitics at the moment,” Executive Director of nonprofit Material Focus in the UK, Scott Butler, told Reuters in front of a giant mound of discarded electronics, which his organization helps collect and ‘mine.’

“All the shenanigans of 2025 with calls on taking over [Greenland], disputes over land in Ukraine, big mines coming in Latin America, and geopolitical relations with China, this is all about the materials that’s inside this urban mine of tech. It’s lithium, it’s cobalt, it’s nickel, it’s gold, it’s aluminum, and steel. And this is why it’s really, really important. This isn’t just a pile of old tech, a pile of mess, this is the future.”

DEScycle uses deep eutectic solvents to extract metals from the UK’s electronic waste that would normally have been sent to Japan. Once there, the plastic components would be incinerated, and the metals recovered in a molten soup. Not only is there a large emissions impact from shipping it to Japan in the first place, but running the furnace as well.

But this is in a case where the E-waste was recycled, which is hardly the norm. In 2024 alone, the UN estimated that some three-fourths of all electronic waste wasn’t accounted for in recycling streams, leaving an estimated $62 billion worth of natural resources buried or sitting idly in landfills.

According to Reuters, DEScycle is set to incorporate its solvent-based method into the waste processing stream of a leading UK recycler, promising progress where little has been made.

Aware of the E-waste problem in its country, however, the Royal Mint has also been investing and sponsoring ways of extracting gold from discarded circuit boards in the UK, and in 2024 they opened a large processing plant for recovering this gold that boasts the capacity to break down 4,000 metric tons of circuit boards every year, amounting to hundreds of kilograms of the yellow metal.

But the really cool thing about the process is that the British government isn’t pocketing the gold, but rather minting standardized gold coins to back the shares of an electronically traded physical gold fund that allows investors to diversify into gold without any environmentally damaging mining activities taking place. Recyclers Switch from Smelting to Solvents, Recovering Precious Metals from E-waste with Fewer Emissions

Read More........

Unique Antibody from Camels and Alpacas Could Be Used to Treat Alzheimer’s

credit, Sung Jin Cho on Unsplash

An antibody-like compound known on land to be exclusively to be found in camelids like alpacas, lamas, and dromedaries, could be used to treat human brain disorders such as Alzheimer’s disease, according to a new study.

The study’s focus were antibody-like proteins, aptly called nanobodies, whose small size allowed the scientists to treat neurological conditions in mice more effectively and with fewer side effects.

The study, published in the journal Trends in Pharmacological Sciences, outlines the next steps towards developing nanobody treatments that are safe for humans.

“Camelid nanobodies open a new era of biologic therapies for brain disorders and revolutionize our thinking about therapeutics,” said Dr. Philippe Rondard, of Centre National de la Recherche Scientifique (CNRS) in France.

“We believe they can form a new class of drugs between conventional antibodies and small molecules.”

Nanobodies were first discovered in the early 1990s by Belgian scientists studying the immune systems of camelids. They found that as well as making conventional antibodies, which are composed of two heavy chains and two light chains, camelids also produce antibodies with just heavy chains.

The antigen-binding fragments of those antibodies are now known as nanobodies. They’re just one-tenth the size of conventional antibodies, and have not been found in any other mammals, say scientists, although they have been observed recently in some cartilaginous fish.

Therapeutic approaches for diseases such as cancer and autoimmune disorders often centre around antibodies. The treatments that have shown some therapeutic benefits, including a few drugs for Alzheimer’s treatment, are often associated with secondary side effects, however.

With their much smaller size, scientists say nanobodies have the potential to offer better efficacy for brain diseases with fewer side effects. In previous studies, the team has shown that nanobodies can restore behavioral deficits in mouse models of schizophrenia and other neurologic conditions.

“These are highly soluble small proteins that can enter the brain passively,” said co-author Dr. Pierre-André Lafon, also of CNRS. “By contrast, small-molecule drugs that are designed to cross the blood-brain barrier are hydrophobic in nature, which limits their bioavailability, increases the risk of off-target binding, and is linked to side effects.”

He says nanobodies are also easier than conventional antibodies to produce, purify, and engineer and can be fine-tuned to their targets.

But the researchers acknowledge that several steps need to be taken before nanobodies can be tested in human clinical trials for brain disorders. They say toxicology and long-term safety testing are essential, and the effect of chronic administration needs to be understood.

“It will be necessary to obtain clinical-grade nanobodies and stable formulations that maintain activity during long-term storage and transport,” said Dr. Rondard.Dr Lafon added that his lab has already started to study these different parameters for a few brain-penetrant nanobodies and has recently shown that conditions of treatment are compatible with chronic treatment.” Unique Antibody from Camels and Alpacas Could Be Used to Treat Alzheimer’s
Read More........

New online tool to transform how high blood pressure is treated

IANS Photo

New Delhi, (IANS): A global team of researchers from India, Australia, the US, and the UK has developed a novel online-based tool which can transform how hypertension is managed, allowing doctors to choose a treatment for each patient based on the degree to which they need to lower their blood pressure.

The 'blood pressure treatment efficacy calculator' is built on data from nearly 500 randomised clinical trials in over 100,000 people. It allows doctors to see how different medications are likely to lower blood pressure.

“We cannot overlook the importance of controlling high blood pressure effectively and efficiently. Achieving optimal control requires a clear understanding of the efficacy of antihypertensive drugs at different doses and in various combinations. Without clarity on what we want to achieve and how to achieve it, we will not meet our targets. Guidelines define the target blood pressure, while our online tool helps identify which antihypertensive drugs are best suited to reach that target,” said Dr. Mohammad Abdul Salam, from The George Institute for Global Health, Hyderabad.

A single antihypertensive medication -- still the most common way treatment is started -- typically lowers systolic BP by just 8-9 mmHg, while most patients need reductions of 15-30 mmHg to reach ideal targets.

Nelson Wang, cardiologist and Research Fellow at the Institute, noted that while the traditional way of doing this is by measuring blood pressure directly for each patient and adjusting treatment accordingly, BP readings are far too variable, or ‘noisy’, for it to be reliable.

The new tool, described in research published in The Lancet, helps overcome this challenge by calculating the average treatment effect seen across hundreds of trials.

It also categorises treatments as low, moderate, and high intensity, based on how much they lower blood pressure (BP) -- an approach already routinely used in cholesterol-lowering treatment.

High blood pressure is one of the world’s biggest health challenges, affecting as many as 1.3 billion people and leading to around ten million deaths each year.Often called a silent killer as it does not cause any symptoms on its own, it can remain hidden until it leads to a heart attack, stroke, or kidney disease. Fewer than one in five people with hypertension have it under control. New online tool to transform how high blood pressure is treated | MorungExpress | morungexpress.com
Read More........

Nagaland University researchers find plant compound to treat diabetic wound, foot ulcers


IANS Photo

New Delhi, (IANS): Researchers at the Nagaland University have identified a naturally occurring plant compound called ‘Sinapic acid’ as a powerful therapeutic agent that can significantly enable wound healing in patients with diabetes.

A diabetic wound is a slow-healing sore, most often a foot ulcer. Also known as diabetic foot, it raises the risk of nerve damage (neuropathy) and poor blood circulation, foot ulcers, infections, and amputation in severe cases.

The study, published in the journal Nature Scientific Reports, demonstrated that oral administration of Sinapic acid can accelerate diabetic wound healing in preclinical models.

Sinapic acid is a naturally occurring antioxidant found in various edible plants.

The research established that the compound works by activating the SIRT1 pathway, which plays a crucial role in tissue repair, angiogenesis, and inflammation control.

The discovery marks a major advancement that could result in safe, natural, and effective treatments for diabetic wound management.

“Diabetes mellitus remains one of the world’s most pressing chronic diseases, affecting hundreds of millions globally. Among its serious complications is delayed wound healing, often resulting in diabetic foot ulcers, infection, and, in severe cases, amputation. Existing synthetic drugs have shown limited efficacy and often cause undesirable side effects,” said Prof. Pranav Kumar Prabhakar, Head, Department of Biotechnology, School of Engineering and Technology, Nagaland University.

“We found that a lower dose (20 mg/kg) was more effective than a higher one (40 mg/kg), a phenomenon known as ‘Inverted Dose-Response.’ This result not only optimises dosage strategy but also has significant clinical implications for future drug development,” he added.

Importantly, the discovery will help reduce the risk of amputation and accelerate recovery in diabetic foot ulcers and providing an affordable, natural oral therapy, improving accessibility for patients in rural and resource-limited settings.The research developed robust preclinical evidence that Sinapic acid enhances wound healing, improves metabolic health, and mitigates oxidative stress in diabetic models. The next phase includes pilot clinical trials, said the researchers. Nagaland University researchers find plant compound to treat diabetic wound, foot ulcers | MorungExpress | morungexpress.com
Read More........

Study shows eye scans may provide clues to ageing, heart disease risk

(Photo: AI generated image/IANS)

New Delhi, (IANS) Canadian researchers have found that scanning the tiny blood vessels in the eyes may help predict a person's risk of developing heart disease and how fast they're biologically ageing.

The study, published in the journal Science Advances, suggests that retinal scans could one day serve as a noninvasive window into the body's overall vascular health and biological ageing status, offering new opportunities for early detection and intervention.

"By connecting retinal scans, genetics, and blood biomarkers, we have uncovered molecular pathways that help explain how aging affects the vascular system," said Marie Pigeyre, Associate Professor at McMaster University’s Department of Medicine in Canada.

"The eye provides a unique, noninvasive view into the body's circulatory system. Changes in the retinal blood vessels often mirror changes occurring throughout the body's small vessels," added Pigeyre.

To conduct the study, the team combined retinal scans, genetic data, and blood sample analyses from over 74,000 participants.

People with simpler, less branched blood vessels were found to be at increased risk of cardiovascular diseases and showed signs of biological ageing, such as higher inflammation and shorter lifespan.

Currently, assessing age-related diseases like heart disease, stroke, and dementia requires multiple tests. The hope is that retinal scans alone could eventually be used as a quick, accessible way to assess ageing and cardiovascular risk. However, more research is needed.

The team also reviewed blood biomarkers and genetic data and identified potential biological causes behind changes in the eye's blood vessels. This helped them identify specific proteins that may drive ageing and disease -- MMP12 and IgG-Fc receptor IIb.

Both proteins are linked to inflammation and vascular ageing. According to Pigeyre, these proteins could be potential targets for future drugs."Our findings point to potential drug targets for slowing vascular ageing, reducing the burden of cardiovascular diseases, and ultimately improving lifespan," she said. Study shows eye scans may provide clues to ageing, heart disease risk | MorungExpress | morungexpress.com
Read More........

Rapid BP fluctuations may signal risk of brain degeneration in elderly

(Photo: AI generated image/IANS)

New Delhi, (IANS) Older adults whose blood pressure fluctuates widely may indicate a greater risk of brain shrinkage and nerve cell injury, according to a new study.

The study, published in the Journal of Alzheimer’s Disease, reveals that short-term “dynamic instability” in blood pressure -- moment-to-moment changes measured over just minutes -- is linked to loss of brain tissue in regions critical for memory and cognition, as well as to blood biomarkers of nerve cell damage.

“Our findings show that even when average blood pressure is normal, instability from one heartbeat to the next may place stress on the brain,” said Daniel Nation, from the University of Southern California’s Leonard Davis School of Gerontology.

“These moment-to-moment swings appear to be associated with the same kinds of brain changes we see in early neurodegeneration,” added the Professor of Gerontology and Medicine.

While high average blood pressure has long been known to increase the risk of dementia, this study focuses on blood pressure variability, or how much blood pressure rises and falls over short time periods.

Recent evidence suggests that such fluctuations can strain small blood vessels in the brain and reduce their ability to deliver steady blood flow.

In this study, the researchers combined two complementary measures: Average Real Variability (ARV) and Arterial Stiffness Index (ASI).

ARV captures how much systolic blood pressure (the top number in a blood pressure reading) changes between each heartbeat, while ASI reflects how flexible or stiff the arteries are as they respond to those changes in pressure.

Together, these measures indicate how much blood flow changes over a short period of time, or what the researchers call “blood pressure dynamic instability.”

"This study suggests that excessive fluctuations could be a sign of vascular ageing that contributes to brain injury,” Nation explained.

The team conducted MRI scans of 105 community-dwelling older adults between the ages of 55 and 89 who were generally healthy and had no major neurological disease.

Participants with both high ARV and high ASI were found to have smaller hippocampal and entorhinal cortex volumes -- brain regions vital for learning and memory, also the first affected by Alzheimer’s disease.

Blood samples showed that the same individuals also had higher levels of neurofilament light (NfL), a blood-based marker that rises when nerve cells are damaged.The findings open a new window into how cardiovascular changes contribute to cognitive decline and may offer novel prevention strategies. Rapid BP fluctuations may signal risk of brain degeneration in elderly | MorungExpress | morungexpress.com
Read More........

A Combination Implant and Augmented Reality Glasses Restores Reading Vision to Blind Eyes

Study participant Sheila Irvine training with the device – credit Moorfields Eye Hospital

A “new era” has begun in the development of artificial vision after a combination electronic eye implant—with augmented reality glasses restored vision to blind eyes in patients with untreatable macular degeneration.

Those treated with the device could read, on average, five lines of a vision chart, even though some could not even see the chart before their surgery.

The results of the European clinical trial which involved 38 patients in 17 hospitals across 5 countries were published in The New England Journal of Medicine. They showed 84% of participants were able to read letters, numbers, and words using prosthetic vision through an eye that had previously lost its sight due to the untreatable progressive eye condition, “geographic atrophy with dry age-related macular degeneration (GA in dry AMD).”

The now-proven device is called PRIMA, and consists of an ultra-thin microchip implanted in the eye that receives infrared projections of the waking world by a video camera installed in a pair of augmented reality classes.

A pocket computer fixed to a small control panel worn on the waistband then runs artificial intelligence algorithms to process the information contained in the infrared projection, which is converted into an electrical signal. This signal passes through the retinal and optical nerve cells into the brain, where it’s interpreted as vision.

The patient uses their glasses to focus and scan across the main object in the projected image from the video camera, using the zoom feature to enlarge the text. Each patient goes through an intensive rehabilitation program over several months to learn to interpret these signals and start reading again.

“In the history of artificial vision, this represents a new era,” said Mr. Mahi Muqit, associate professor at the UK’s University College London’s Institute of Ophthalmology and consultant at Moorfields Eye Hospital where the UK arm of the trial was conducted.

“Blind patients are actually able to have meaningful central vision restoration, which has never been done before.”

“Getting back the ability to read is a major improvement in their quality of life, lifts their mood and helps to restore their confidence and independence. The PRIMA chip operation can safely be performed by any trained vitreoretinal surgeon in under two hours—that is key for allowing all blind patients to have access to this new medical therapy for GA in dry AMD.”

Dry AMD is a slow deterioration of the cells of the macula over many years, as the light-sensitive retinal cells die off. For most people with dry AMD, they can experience a slight loss of central vision.

Through a process known as geographic atrophy (GA), it can progress to full vision loss in the eye, as the cells die and the central macula melts away. There is currently no treatment for GA, which affects 5 million people globally. All participants in this trial had lost the central sight of the eye being tested, leaving only limited peripheral vision.

Scans of the implant in a patient’s eye – credit Science Corporation

The procedure in install the implant involves a vitrectomy, where the eye’s vitreous jelly is removed from between the lens and the retina, and the surgeon inserts the ultra-thin microchip, which is shaped like a SIM card and just 2mm x 2mm.

The PRIMA System device used in this operation is being developed by Science Corporation, which develops brain-computer interfaces and neural engineering. No significant decline in existing peripheral vison was observed in trial participants, and these findings pave the way for seeking approval to market this new device.

UCL spoke with one of the patients who received the implant for the college’s news outlet.

“I wanted to take part in research to help future generations, and my optician suggested I get in touch with Moorfields,” began Sheila Irvine, one of Moorfields’ patients on the trial. “Before receiving the implant, it was like having two black discs in my eyes, with the outside distorted.

“I was an avid bookworm, and I wanted that back. I was nervous, excited, all those things. There was no pain during the operation, but you’re still aware of what’s happening. It’s a new way of looking through your eyes, and it was dead exciting when I began seeing a letter. It’s not simple, learning to read again, but the more hours I put in, the more I pick up.”

“The team at Moorfields has given me challenges, like ‘Look at your prescription,’ which is always tiny. I like stretching myself, trying to look at the little writing on tins, doing crosswords.”

The global trial was led by Dr. Frank Holz of the University of Bonn, with participants from the UK, France, Italy, and the Netherlands.

Mr. Muqit that it left him feeling that a door was opened for medical devices in this area, because there is no treatment currently licensed for dry AMD.“I think it’s something that, in future, could be used to treat multiple eye conditions.” A Combination Implant and Augmented Reality Glasses Restores Reading Vision to Blind Eyes
Read More........

First Antidote for Carbon Monoxide Poisoning 'Cleans' Blood in Minutes

A plug-in carbon monoxide detector – credit Fastily CC 4.0. BY-SA

It’s invisible, it’s lethal, and it’s been with us for decades, but carbon monoxide poisoning can now be fought with the first-ever antidote that rapidly removes the toxic molecule from the bloodstream.

Carbon monoxide or CO, poisoning accounts for 50,000 emergency room visits in the US each year and causes about 1,500 deaths, each one being lamented as a shameful waste and tragic oversight.

Currently, the only treatments for CO poisoning are oxygen-based therapies, which help the body eliminate the toxic gas. However, even with treatment, nearly half of survivors suffer long-term heart and brain damage. This has created an urgent need for faster, more effective interventions.

In a study published by University of Maryland School of Medicine (UMSOM) in PNAS, the research team developed a new engineered protein-based therapy called RcoM-HBD-CCC, which acts like a sponge to soak up carbon monoxide from the blood.

RcoM (short for “regulator of metabolism”) is a natural protein isolated from the bacterium Paraburkholderia xenovorans which uses it to sense minute levels of carbon monoxide in its environment.

The researchers engineered a version that is highly selective, grabbing CO without interfering with oxygen or other important molecules in the bloodstream like nitric oxide, which is vital for the regulation of blood pressure.

In tests on mice, the new therapy worked quickly to remove CO from red blood cells and was safely flushed out of the body through urine.

CO is known commonly as the “silent killer,” because this odorless, invisible gas, typically released from combustion sources, including stovetops, propane heaters, car exhausts, and firewood, poisons in a gradual manner that isn’t immediately obvious to the victim.

In healthy bodies, oxygen inhaled from the air binds to the protein hemoglobin on the surface of red blood cells, which then ferry the oxygen to all the tissues of the body. CO however, competes with oxygen for hemoglobin. It enters the bloodstream and binds to hemoglobin with a 200 to 400-fold greater affinity than oxygen. That means CO hogs most of the hemoglobin seats, so not enough oxygen molecules can get a ride to the tissues that need them.

Currently, the only available treatments for carbon monoxide poisoning involve giving 100% pure oxygen, sometimes under pressure in a hyperbaric chamber.

All too often, patients are not transported, diagnosed, and treated in time to reverse the effects of CO poisoning, which can cause lasting cardiac and neurological injuries or even death.

Infused in the bloodstream, scavenger hemoproteins like RcoM-HBD-CCC rapidly bind to carbon monoxide molecules, reducing the time it takes to clear half of the carbon monoxide in the blood to less than a minute, compared to more than hour with pure oxygen therapy and five hours without any treatment.

A potential drawback the researchers were aware of is that so-called “scavengers” like RcoM also have an affinity for oxygen, and so may uptake the nitric oxide mentioned earlier. This can cause wild and potentially unsafe changes in blood pressure, but RcoM-HBD-CCC caused no such side effects.

“Unlike other protein-based treatments, we found the compound caused only minimal changes in blood pressure, which was an exciting finding and raised the potential for this new molecule to have clinical applications,” said study corresponding author Mark T. Gladwin, MD, Dean of UMSOM.

“This has the potential to become a rapid, intravenous antidote for carbon monoxide that could be given in the emergency department or even in the field by first-responders.”Future studies will likely include more pre-clinical research to determine the safe and effective dosage range for RcoM-HBD-CCC in treating carbon monoxide poisoning. It could also form the basis for new research in other fields, including as an oxygen delivery therapy or blood substitute. This could include hemorrhagic shock, acute respiratory distress syndrome (ARDS), severe anemias, and the preservation of organs for transplantation. First Antidote for Carbon Monoxide Poisoning 'Cleans' Blood in Minutes
Read More........

Poor sleep may make your brain age faster – new study

Abigail Dove, Karolinska Institutet

We spend nearly a third of our lives asleep, yet sleep is anything but wasted time. Far from being passive downtime, it is an active and essential process that helps restore the body and protect the brain. When sleep is disrupted, the brain feels the consequences – sometimes in subtle ways that accumulate over years.

In a new study, my colleagues and I examined sleep behaviour and detailed brain MRI scan data in more than 27,000 UK adults between the ages of 40 and 70. We found that people with poor sleep had brains that appeared significantly older than expected based on their actual age.

What does it mean for the brain to “look older”? While we all grow chronologically older at the same pace, some people’s biological clocks can tick faster or slower than others. New advances in brain imaging and artificial intelligence allow researchers to estimate a person’s brain age based on patterns in brain MRI scans, such as loss of brain tissue, thinning of the cortex and damage to blood vessels.

In our study, brain age was estimated using over 1,000 different imaging markers from MRI scans. We first trained a machine learning model on the scans of the healthiest participants – people with no major diseases, whose brains should closely match their chronological age. Once the model “learned” what normal ageing looks like, we applied it to the full study population.

Having a brain age higher than your actual age can be a signal of departure from healthy ageing. Previous research has linked an older-appearing brain to faster cognitive decline, greater dementia risk and even higher risk of early death.

Sleep is complex, and no single measure can tell the whole story of a person’s sleep health. Our study, therefore, focused on five aspects of sleep self-reported by the study participants: their chronotype (“morning” or “evening” person), how many hours they typically sleep (seven to eight hours is considered optimal), whether they experience insomnia, whether they snore and whether they feel excessively sleepy during the day.

These characteristics can interact in synergistic ways. For example, someone with frequent insomnia may also feel more daytime sleepiness, and having a late chronotype may lead to shorter sleep duration. By integrating all five characteristics into a “healthy sleep score”, we captured a fuller picture of overall sleep health.

People with four or five healthy traits had a “healthy” sleep profile, while those with two to three had an “intermediate” profile, and those with zero or one had a “poor” profile.

When we compared brain age across different sleep profiles, the differences were clear. The gap between brain age and chronological age widened by about six months for every one point decrease in healthy sleep score. On average, people with a poor sleep profile had brains that appeared nearly one year older than expected based on their chronological age, while those with a healthy sleep profile showed no such gap.

We also considered the five sleep characteristics individually: late chronotype and abnormal sleep duration stood out as the biggest contributors to faster brain ageing.

A year may not sound like much, but in terms of brain health, it matters. Even small accelerations in brain ageing can compound over time, potentially increasing the risk of cognitive impairment, dementia and other neurological conditions.

The good news is that sleep habits are modifiable. While not all sleep problems are easily fixed, simple strategies: keeping a regular sleep schedule; limiting caffeine, alcohol and screen use before bedtime; and creating a dark and quiet sleep environment can improve sleep health and may protect brain health.

How exactly does the quality of a person’s sleep affect their brain health?

One explanation may be inflammation. Increasing evidence suggests that sleep disturbances raise the level of inflammation in the body. In turn, inflammation can harm the brain in several ways: damaging blood vessels, triggering the buildup of toxic proteins and speeding up brain cell death.

We were able to investigate the role of inflammation thanks to blood samples collected from participants at the beginning of the study. These samples contain a wealth of information about different inflammatory biomarkers circulating in the body. When we factored this into our analysis, we found that inflammation levels accounted for about 10% of the connection between sleep and brain ageing.

Other processes may also play a role

Another explanation centres on the glymphatic system – the brain’s built-in waste clearance network, which is mainly active during sleep. When sleep is disrupted or insufficient, this system may not function properly, allowing harmful substances to build up in the brain.

Yet another possibility is that poor sleep increases the risk of other health conditions that are themselves damaging for brain health, including type 2 diabetes, obesity and cardiovascular disease.

Our study is one of the largest and most comprehensive of its kind, benefiting from a very large study population, a multidimensional measure of sleep health, and a detailed estimation of brain age through thousands of brain MRI features. Though previous research connected poor sleep to cognitive decline and dementia, our study further demonstrated that poor sleep is tied to a measurably older-looking brain, and inflammation might explain this link.

Brain ageing cannot be avoided, but our behaviour and lifestyle choices can shape how it unfolds. The implications of our research are clear: to keep the brain healthier for longer, it is important to make sleep a priority.The Conversation

Abigail Dove, Postdoctoral Researcher, Neuroepidemiology, Karolinska Institutet

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Read More........

The Subtle Power of Unhearable Sound: Mood and Cognition-Altering Agents

For representational purpose (Image by Gerd Altmann from Pixabay)

Shreyas Kannan, Plaksha University: The human ear has a maximum hearing range of 20 Hz to 20,000 Hz. However, in all reality the range at which we are most sensitive is from 1000 Hz to 4000 Hz at which most natural speech occurs. As frequency decreases, the sound energy or decibels needed to hear sounds increases, which makes the sound effectively “too soft” unless played at a high enough volume. What this means is that the lower and higher frequencies are both difficult to perceive normally, and frequencies outside of this range entirely, Infrasound, which vibrates below 20 Hz, and ultrasound, which is above 20,000 Hz, are simply imperceptible.

These imperceptible sounds however, have a very perceptible effect. Vic Tandy, a British engineer, believed his laboratory was haunted—until he discovered that a silent 19 Hz sound wave, produced by a fan, was resonating with his eyeballs and triggering shadowy hallucinations. Even though these sounds were below the threshold of human hearing, it could still alter mood, physiology, and cognition.

Infrasound and ultrasound can also have indirect subliminal effects. They can very subtly and over long durations of time have a negative or positive effect on the psyche of the listener. Infrasound, although inaudible, can cause a range of adverse effects, including fatigue, sleep disturbance, and cognitive dysfunction.

How does this work, especially for sounds we can’t even hear? The sounds in the Ultrasonic range tend to stimulate the emotional centers of the brain, which generally are the amygdala and hippocampus, to name a few. A study proceeded to track this and found that sounds containing inaudible high-frequency components induced activation in deep brain structures associated with emotion and reward. This effectively demonstrates a reflexive unconscious emotional response, be it positive or negative, toward a specific band of sound frequencies.

The issues do not end here. There is a persistent worry of chronic exposure to just basic sound, not just ultrasonic or infrasonic sound, having long term effects on the brain. Symptoms such as ‘chronic fatigue,’ ‘repeated headache,’ and ‘backache’ are observed to be highly associated with low- and mid-octave band center frequency noise exposure among the sampled workers. Among the major psychological symptoms... It is evident that ‘irritability’ is highly associated with low- and mid-octave band noise frequency characteristics. In conclusion even when the noise isn't painfully loud, its frequency can still degrade physical and mental health over time which should be raising ethical and public health concerns.

These effects, as can be surmised, are highly weaponizable “smart consumer devices produce possibly imperceptible sound at both high (17–21kHz) and low (60–100Hz) frequencies, at the maximum available volume setting, potentially turning them into acoustic cyber-weapons.”

The physical and systemic effects that can be caused by long exposure to something that can technically originate from our devices, especially considering previously what the Infrasonic and ultrasonic bands can potentially do. Overall, we find that many of the devices tested are capable of reproducing frequencies within both high and low ranges, at levels exceeding those recommended in published guidelines. Such attacks are often trivial to develop and, in many cases, could be added to existing malware payloads, as they may be attractive to adversaries with specific motivations or targets.

One particular patent actually claims that 1/2 Hz frequency (Around 0.5 Hz) affects the autonomic nervous system and can produce a variety of effects, not limited to Eyelid drooping (ptosis) Relaxation and drowsiness Feeling of pressure on the forehead Visual effects with eyes closed Stomach sensations Tenseness (at certain frequencies). It goes on to propose how this can be used in law enforcement in the form of Non-lethal crowd control Creating disorientation in standoff situations and Remote manipulation from a distance. It goes on to list the effects of the 2.5 Hz range and the other set of effects this has.

However, not all sound effects are bad. Certain ways of application of sound can be used to actually help treat mental issues. One example is through the use of binaural beats, a form of imperceptible or subtle auditory stimulation, which are being studied for their effects on mood regulation, anxiety, and depression. Binaural beats are a type of sound that can influence brainwave activity by playing two slightly different frequencies in each ear, creating a perceived third “beat” in the brain in the way of a non-invasive sound-based intervention. A systematic study conducted to this end found positive effects in the short term while stressing that further research was needed in the long term to determine the full scope of positive effects.

It should also be noted that while these frequencies can be used negatively, it is perfectly possible for them to be used positively. Playing the right type of sound, be it music or a particular frequency set at a volume too low to be heard tended to elicit a positive response on mood and well being.

From the different sources of literature and patent claims, it can be surmised that with the exact know-how and mapping of which exact frequency to use to affect a person in a certain manner, one could be completely manipulated to actually feel a certain way about a topic that we might actually dislike. Any emotion can be aroused as necessary. Furthermore, it can be done through the speakers in everyday devices! An advertisement for a product could play the right sounds to make you view it more favourably, documentaries could potentially use this to make you feel particularly worse about a certain topic to increase the impact, electoral candidates can subtly change their image playing the right sounds at the right time, interviewees could potentially be influenced to feel uneasy for no ‘explainable’ reason as a form of sabotage, etc! The actual potential for abuse of the sounds we cannot even hear, is extreme.

How can we protect ourselves from these phenomena? The answer is quite difficult, especially at this age where sounds come from everywhere around us. The solution to this is to call for scientific transparency, proper protocols to monitor the actual playing sounds and strictly maintaining awareness of one's surroundings. In this day and age we must learn to listen to sounds that we cannot hear.Shreyas Kannan is a B.Tech student in Robotics and Cyber-Physical Systems (RCPS) at Plaksha University, and part of its inaugural graduating batch. He has an ardent passion for all things related to movement and propulsion in vehicles, and brings boundless curiosity and energy to projects that make objects move—whether on land, underwater, or in space. From autonomous underwater navigation to aerospace systems, Shreyas is eager to explore and contribute to the frontier of motion-driven technologies. The Subtle Power of Unhearable Sound: Mood and Cognition-Altering Agents | MorungExpress | morungexpress.com
Read More........

Indian researchers develop diagnostic device to detect early-stage bone cancer



New Delhi, (IANS) In a major scientific breakthrough, researchers from IIT (BHU) in Uttar Pradesh have developed a miniaturised, self-reporting diagnostic device that can detect early-stage bone cancer with high precision.

The first-of-its-kind sensor detects osteopontin (OPN) -- a key biomarker for bone cancer.

The device is reagent-free, portable, and cost-effective and is ideal for rural healthcare, said the research team led by Dr. Pranjal Chandra from the School of Biochemical Engineering.

The device works much like a glucose metre and enables quick, accurate, and on-the-spot detection, even in resource-limited settings.

The device uses a custom sensor surface composed of gold and redox-active nanomaterials, allowing it to function similarly to a glucose meter.

“This technology simplifies cancer detection and empowers primary health centres,” said Prof. Chandra. The findings are published in the prestigious journal Nanoscale (Royal Society of Chemistry, UK).

OPN is a crucial biomarker associated with osteosarcoma -- a highly aggressive form of bone cancer that primarily affects children and adolescents.

While current methods to detect OPN are costly and time-consuming, the new device offers rapid and accurate results with minimal equipment.

It is designed as a reagent-less immunosensor, which enables on-the-spot and affordable testing. It is especially beneficial in rural and resource-constrained areas where early cancer detection is often delayed.

Cancer is a major public health concern in India, with rising incidence rates and significant mortality.

Lauding the innovation, Director Prof. Amit Patra called it “a prime example of technology with a human face”. He said it contributes to precision medicine and national health priorities. He added that the innovation aligns with the government's Make in India and Start-up India initiatives.A patent application has been filed, and efforts are underway to convert the prototype into a smartphone-compatible diagnostic kit for remote healthcare access, the researchers said. Indian researchers develop diagnostic device to detect early-stage bone cancer | MorungExpress | morungexpress.com
Read More........